Every 424B that SCHMID Group N.V. (SHMD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow SHMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SHMD filings page.
SCHMID Group N.V. is registering up to 46,611,659 Ordinary Shares for issuance and up to 89,341,198 Ordinary Shares for resale by selling securityholders. The issuance shares relate to exercises of warrants, conversions of convertible notes and the 2025 Convertible Loan, 2025 Options, and management incentive plans. Actual shares issued may be materially lower than the registered maximums. SCHMID receives no proceeds from selling-securityholder resales, but may receive proceeds from cash exercises of warrants or options; warrants may also be exercised on a cashless basis.
For the six months ended June 30, 2026, revenue was €46.0 million, versus €16.9 million a year earlier, while net loss was €47.8 million versus €10.2 million, primarily reflecting non-cash effects. Adjusted EBITDA was a loss of €0.6 million, compared with a loss of €11.6 million. SCHMID maintained 2026 revenue guidance above €100 million and order-intake guidance of €125–150 million, but lowered its Adjusted EBITDA margin guidance to 6% to 9% from more than 12%.
SCHMID Group N.V. (SHMD) registered up to 5,000,000 ordinary shares for resale by Yorkville: up to 4,975,111 shares the company may elect to issue and sell under its Standby Equity Purchase Agreement (SEPA), plus 24,889 commitment shares. At its discretion and subject to the SEPA’s conditions, SCHMID may sell shares to Yorkville under an up-to-$30,000,000 commitment. SCHMID had issued 1,490,000 shares under the SEPA, leaving 3,510,000 registered shares available for future issuance and sale. SCHMID will not receive proceeds from Yorkville’s resales; it had received approximately $9.0 million from SEPA sales and may receive up to approximately $21 million in further gross proceeds.
For the six months ended June 30, 2026, revenue was €46.0 million versus €16.9 million a year earlier, while Adjusted EBITDA was a loss of €0.6 million versus a loss of €11.6 million. Net loss was €47.8 million, primarily reflecting non-cash accounting effects. Full-year 2026 revenue guidance remained above €100 million; Adjusted EBITDA margin guidance was lowered to 6%–9% from previously more than 12%, and order intake guidance remained €125–150 million.
SCHMID Group N.V. registers 4,958,481 Ordinary Shares for resale by Christine Schmid, Anette Schmid, Christian Schmid and Schmid Grundstücke GmbH & Co KG. Issued on May 23, 2026 to offset EUR 30.75 million of liabilities, the shares may be sold for the holders’ own accounts; registration does not mean they will sell, and SCHMID will receive no proceeds from resales.
For the six months ended June 30, 2026, revenue was €46.0 million, compared with €16.9 million a year earlier. Gross profit was €9.8 million, versus a €1.6 million loss; net loss was €47.8 million, compared with €10.2 million. Adjusted EBITDA was a loss of €0.6 million, versus a loss of €11.6 million. SCHMID attributed most of the net loss to noncash accounting effects from the XJ Harbour liability conversion and, to a lesser extent, warrant fair-value movements. Full-year 2026 revenue guidance remained above €100 million; Adjusted EBITDA margin guidance was lowered to 6% to 9% from previously more than 12%, while order-intake guidance remained €125 million to €150 million, with SCHMID expecting the upper half of that range.
SCHMID Group N.V. is registering for resale by selling securityholders up to 10,362,693 Ordinary Shares issuable upon conversion of its 2029 Convertible Notes. The notes have $20 million in aggregate principal, bear 5.000% annual interest, and carry a conversion-price floor of USD 1.93 and a maximum of USD 10.50 per Ordinary Share. SCHMID receives no proceeds from resales.
For the six months ended June 30, 2026, revenue was €46.0 million, versus €16.9 million a year earlier. Net loss was €47.8 million versus €10.2 million, impacted mostly by non-cash effects, and operating activities used €29.3 million of cash. SCHMID confirmed 2026 revenue guidance of more than €100 million and order intake guidance of €125 million to €150 million, but lowered Adjusted EBITDA margin guidance to 6% to 9% from more than 12%. NASDAQ confirmed compliance on February 19, 2026, with a mandatory panel monitoring period through February 19, 2027.
SCHMID Group N.V. (SHMD) filed a prospectus supplement for a resale registration of up to 10,362,693 Ordinary Shares, all issuable upon conversion of its 2029 Convertible Notes, by existing selling securityholders. SCHMID will not sell shares itself under this supplement. The Ordinary Shares trade on Nasdaq under ticker SHMD, with a last reported price of $4.91 on August 21, 2026.
The supplement also includes SCHMID’s unaudited H1 2026 results and updated 2026 outlook. Revenue for the first half of 2026 rose to €46.0 million from €16.9 million in H1 2025, driven by Technical Equipment & Processes revenue of €39.4 million. Despite this, net loss widened to €47.8 million, mainly due to a €38.8 million negative financial result and higher expenses. Adjusted EBITDA was €-0.6 million.
Order intake reached €96.6 million year-to-date as of August 21, 2026, with order backlog at €95.0 million. SCHMID reaffirmed 2026 revenue guidance of more than €100 million and order intake guidance of €125–150 million but reduced its 2026 Adjusted EBITDA margin guidance to 6–9% from previously more than 12%. Liquidity improved following issuance of $20.0 million 2029 Convertible Notes, bringing cash to about €14.3 million as of July 31, 2026, and management expects available liquidity and operating cash flows to fund operations for at least the next twelve months.
SCHMID Group N.V. (SHMD) filed a prospectus supplement for the resale of 4,958,481 Ordinary Shares previously issued in a May 23, 2026 private placement; the shares are being sold from time to time by existing securityholders. SCHMID’s Ordinary Shares trade on Nasdaq under “SHMD,” with a last reported price of $4.91 on August 21, 2026.
For the first half of 2026, SCHMID reported revenue of €46.0 million, up from €16.9 million a year earlier, but a net loss of €47.8 million and negative operating cash flow of €29.3 million. Order intake reached €96.6 million year-to-date and order backlog was €95.0 million as of August 21, 2026, supporting confirmed 2026 revenue guidance of more than €100 million. However, full-year Adjusted EBITDA margin guidance was cut to 6–9% from more than 12%. Liquidity improved following convertible note financings, with cash and cash equivalents of about €14.3 million as of July 31, 2026 and roughly $21 million still available under a standby equity purchase agreement. The company outlines significant potential dilution from outstanding convertibles and warrants and provides illustrative dilution scenarios of up to 20% new shares versus the current 60,958,903 Ordinary Shares.
SCHMID Group N.V. (SHMD) filed a prospectus supplement for the resale of up to 5,000,000 Ordinary Shares by existing selling securityholders and, at the same time, furnished H1 2026 results and updated guidance. The shares trade on Nasdaq under SHMD, with a last reported price of $4.91 on August 21, 2026.
For the six months ended June 30, 2026, revenue rose to €46.0 million from €16.9 million a year earlier, but the company reported a net loss of €47.8 million, largely driven by a €38.8 million negative financial result. Adjusted EBITDA was €-0.6 million, excluding restructuring, share-based compensation, capital structure costs and FX effects.
Order intake reached €96.6 million year-to-date by August 21, 2026, with order backlog of €95.0 million. Full-year 2026 revenue guidance of more than €100 million is confirmed, while Adjusted EBITDA margin guidance is reduced to 6–9%. Management highlights improved liquidity after convertible financings and sets out detailed potential dilution scenarios from convertibles and warrants.
SCHMID Group N.V. (SHMD) updates a resale shelf covering 42,729,539 Ordinary Shares, additional Ordinary Shares issuable from various convertible notes, warrants, options and bonus plans, and 9,750,000 Warrants, and attaches its H1 2026 results and revised 2026 outlook.
For the six months ended June 30, 2026, revenue rose to €46.0 million from €16.9 million a year earlier, with Technical Equipment & Processes growing from €10.7 million to €39.4 million and spare parts & services to €6.4 million. Net loss widened to €47.8 million, largely due to a €38.8 million negative financial result; Adjusted EBITDA improved to €-0.6 million from €-11.6 million.
Order intake accelerated to €96.6 million year-to-date by August 21, 2026, with backlog at €95.0 million. The company confirms 2026 revenue guidance of more than €100 million and order-intake guidance of €125–150 million, but lowers its 2026 Adjusted EBITDA margin target to 6–9% from more than 12%. Liquidity improved, with cash and cash equivalents of €14.3 million as of July 31, 2026 after funding new 2029 Convertible Notes, and management expects available liquidity and cash flows to cover operations for at least the next twelve months.
SCHMID Group N.V. is registering for resale by selling securityholders up to 10,362,693 Ordinary Shares issuable upon conversion of its $20 million 5.000% senior convertible notes due 2029. These shares are being offered on a continuous basis by the note investors.
The company will not receive any proceeds from these resales, though it did receive the original note financing. The notes convert within a price band from $1.93 (floor) to $10.50 per share. Ordinary Shares outstanding were 65,675,726 including 5,000,000 unvested earn-out shares; if all registered shares are issued, outstanding shares would rise to 76,038,419.
SCHMID is an emerging growth company, a foreign private issuer, and a controlled company on Nasdaq, with the Schmid family holding just over half of the equity. The prospectus also describes multiple recent financings, a new China manufacturing campus project, and 2026 guidance of more than €100 million in revenue with an EBITDA margin above 12%.
SCHMID Group N.V. filed a resale registration covering 4,958,481 Ordinary Shares issued on May 23, 2026 to four subscribing shareholders to offset aggregate financial liabilities of €30.75 million. The shares were issued under subscription and set‑off agreements with the subscribing securityholders.
The prospectus states these shares may be sold by the selling securityholders at prevailing or negotiated prices and that the company will receive no proceeds from those resales. The company reports 64,985,726 Ordinary Shares outstanding (including 5,000,000 earn‑out shares not vested) and that majority shareholders Anette and Christian Schmid together control 31,357,893 shares (52.27%).
SCHMID Group N.V. registers up to 5,000,000 Ordinary Shares for resale by YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (SEPA) that gives the company the option to sell newly issued shares to Yorkville.
The registration covers up to 5,000,000 Ordinary Shares (including 24,889 Commitment Shares) that the company may elect to issue and sell to Yorkville; the SEPA contemplates up to $30,000,000 of purchases by Yorkville subject to the SEPA terms and conditions. The resale registration does not obligate Yorkville to sell any shares, and the company will not receive proceeds from shares sold by Yorkville under this prospectus. The company may, at its discretion, issue shares to Yorkville under the SEPA from time to time until May 12, 2028.
SCHMID Group N.V. files a shelf prospectus to register up to 46,611,659 Ordinary Shares, including shares issuable on warrants, convertible notes, a 2025 convertible loan, options and management plans.
The prospectus also registers for resale up to 95,040,523 Ordinary Shares (and up to 9,750,000 Private Warrants) held by selling securityholders. The company discloses 55,602,966 Ordinary Shares outstanding and states that full issuance of the registered securities would result in 102,214,670 Ordinary Shares outstanding on a fully diluted basis. The company warns that sales by selling securityholders could depress the share price. The filing notes a going concern qualification tied to obtaining additional financing and that funding of the second $15,000,000 tranche of the 2026 Convertible Notes is conditioned on the effectiveness of this registration statement.